ALT The Helmsley Charitable Trust has awarded a grant of $3,035,566 to support groundbreaking research on Crohn’s disease, to be led by a collaborative team of leading researchers across three institutions. Louis J. Cohen, MD, Assistant Professor of Medicine (Gastroenterology) at the Icahn School of Medicine at Mount Sinai; Parakkal Deepak, MD, Associate Professor of Medicine (Gastroenterology), Washington University School of Medicine; and Andres J. Yarur, MD, Associate Professor of Medicine (Gastroenterology), Cedars-Sinai Medical Center, will serve as co-investigators. This grant will fund an investigation aimed at better understanding how glucagon-like peptide 1 agonists can be used to treat people with Crohn’s disease. Known as GLP-1 agonists, this class of drugs has become widely available in recent years for the treatment of diabetes and obesity. The collaborative project, titled “The Use of GLP-1R Agonists to Promote Epithelial Healing in Crohn’s disease,” will last three years.